Why the study?
Radical nephrectomy with thrombectomy for renal cell carcinoma extending to the right atrium improves survival but carries significant perioperative morbidity and mortality.
Does a novel milking technique via abdominal access allow for safe and effective radical nephrectomy and thrombectomy in patients with RCC extending to the right atrium?
Does a novel milking technique via abdominal access allow for safe and effective radical nephrectomy and thrombectomy in patients with RCC extending to the right atrium?
A novel milking technique via pure transabdominal access allows for successful radical nephrectomy and thrombectomy in selected patients with RCC extending to the right atrium without the need for sternotomy or cardiopulmonary bypass.
May enable less invasive RA thrombus management in RCC; leaves open safety and efficacy pending prospective validation.
Background Radical nephrectomy with thrombectomy in patients with renal cell carcinoma (RCC) and level IV thrombus extending to the right atrium (RA) offers improved survival. However, this procedure is associated with significant perioperative morbidity and mortality. In this report, we describe a novel milking technique for patients with RA tumor thrombus using abdominal access, which does not require diaphragmic incision, sternotomy, right atriotomy, or cardiopulmonary bypass (CPB). Methods Between January 2019 and January 2022, four patients underwent resection of renal cell carcinoma extending into RA by a milking technique developed to avoid diaphragmic incision, sternotomy, or CPB. Patient characteristics, perioperative data, pathological features, and survival were evaluated. Results Complete resection was successful through pure transabdominal access without diaphragmic incision, sternotomy, or CPB in all patients. Conclusion We conclude that radical nephrectomy and thrombectomy in optimized cases with renal cell carcinoma extending into RA can be safely and effectively performed without diaphragmic incision, sternotomy, or CPB, avoiding serious perioperative complications while providing acceptable oncological outcomes.
No takes yet. Share an insight, caveat, or question.
He et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: